Gregory Deno

725 total citations
13 papers, 597 citations indexed

About

Gregory Deno is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Gregory Deno has authored 13 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Gregory Deno's work include Chemokine receptors and signaling (8 papers), Immune Response and Inflammation (5 papers) and Immunotherapy and Immune Responses (5 papers). Gregory Deno is often cited by papers focused on Chemokine receptors and signaling (8 papers), Immune Response and Inflammation (5 papers) and Immunotherapy and Immune Responses (5 papers). Gregory Deno collaborates with scholars based in United States, United Kingdom and Belgium. Gregory Deno's co-authors include R. William Hipkin, Waldemar Gonsiorek, Xuedong Fan, Daniel Lundell, Jay S. Fine, Motasim Billah, James Fossetta, Jo Van Damme, Galya Vassileva and Ghislain Opdenakker and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Gregory Deno

13 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory Deno United States	12	311	255	179	69	62	13	597
Reza Mirzaei Iran	15	366 1.2×	251 1.0×	259 1.4×	72 1.0×	26 0.4×	37	774
April M. Fischer United States	8	317 1.0×	205 0.8×	324 1.8×	35 0.5×	29 0.5×	8	758
Katharina Hochheiser Germany	12	444 1.4×	160 0.6×	212 1.2×	29 0.4×	27 0.4×	17	705
Qiaoling Liang United States	11	256 0.8×	74 0.3×	230 1.3×	74 1.1×	183 3.0×	21	621
Peter D. Koch United States	11	393 1.3×	161 0.6×	231 1.3×	37 0.5×	34 0.5×	20	679
Rose M. Tidwell United States	8	323 1.0×	270 1.1×	252 1.4×	66 1.0×	140 2.3×	8	760
Jennie Karlsson Sweden	12	325 1.0×	64 0.3×	436 2.4×	37 0.5×	45 0.7×	18	582
B. Damerau Germany	15	318 1.0×	37 0.1×	180 1.0×	55 0.8×	88 1.4×	43	687
Sun Jung Lee United States	8	427 1.4×	208 0.8×	147 0.8×	24 0.3×	57 0.9×	8	668
Gretchen N. Schwartz United States	15	237 0.8×	172 0.7×	210 1.2×	36 0.5×	27 0.4×	33	616

Countries citing papers authored by Gregory Deno

Since Specialization

Citations

This map shows the geographic impact of Gregory Deno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Deno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Deno more than expected).

Fields of papers citing papers by Gregory Deno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Deno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Deno. The network helps show where Gregory Deno may publish in the future.

Co-authorship network of co-authors of Gregory Deno

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Deno. A scholar is included among the top collaborators of Gregory Deno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Deno. Gregory Deno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Chapman, Richard W., Michael Minnicozzi, Chander Celly, et al.. (2007). A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation. Journal of Pharmacology and Experimental Therapeutics. 322(2). 486–493. 116 indexed citations

Gonsiorek, Waldemar, Charles A. Lunn, Xuerong Fan, et al.. (2007). Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB₂) in rodents and primates. British Journal of Pharmacology. 151(8). 1262–1271. 14 indexed citations

Gonsiorek, Waldemar, Xuedong Fan, David Hesk, et al.. (2007). Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist. Journal of Pharmacology and Experimental Therapeutics. 322(2). 477–485. 101 indexed citations

Gonsiorek, Waldemar, David Hesk, Shu‐Cheng Chen, et al.. (2006). Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336. Journal of Biological Chemistry. 281(38). 28143–28151. 20 indexed citations

Fan, Xuedong, Andriani C. Patera, Gregory Deno, et al.. (2006). Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8. Journal of Biological Chemistry. 282(16). 11658–11666. 171 indexed citations

Fossetta, James, Gregory Deno, Waldemar Gonsiorek, et al.. (2004). Pharmacological characterization of human S1P₄ using a novel radioligand, [4,5‐³H]‐dihydrosphingosine‐1‐phosphate. British Journal of Pharmacology. 142(5). 851–860. 9 indexed citations

Hipkin, R. William, Gregory Deno, Jay S. Fine, et al.. (2004). Cloning and Pharmacological Characterization of CXCR1 and CXCR2 from Macaca fascicularis. Journal of Pharmacology and Experimental Therapeutics. 310(1). 291–300. 11 indexed citations

Fine, Jay S., Alberto Rojas-Triana, James V. Jackson, et al.. (2003). Impairment of Leukocyte Trafficking in a Murine Pleuritis Model by IL-4 and IL-10. Inflammation. 27(4). 161–174. 20 indexed citations

Fossetta, James, James Jackson, Gregory Deno, et al.. (2003). Pharmacological Analysis of Calcium Responses Mediated by the Human A3 Adenosine Receptor in Monocyte-Derived Dendritic Cells and Recombinant Cells. Molecular Pharmacology. 63(2). 342–350. 51 indexed citations

10.

Chou, Chuan‐Chu, Jay S. Fine, Catherine Pugliese‐Sivo, et al.. (2002). Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL‐60 cells: antagonism of hCCR1 activation by MIP‐1β. British Journal of Pharmacology. 137(5). 663–675. 31 indexed citations

11.

Kaminski, Henry J., et al.. (1999). Macrophage Inflammatory Protein-3β Enhances IL-10 Production by Activated Human Peripheral Blood Monocytes and T Cells. The Journal of Immunology. 163(9). 4715–4720. 17 indexed citations

12.

Kaminski, Henry J., et al.. (1999). Macrophage inflammatory protein-3 beta enhances IL-10 production by activated human peripheral blood monocytes and T cells.. PubMed. 163(9). 4715–20. 19 indexed citations

13.

O’Brien, Kathryn, et al.. (1992). Integration host factor facilitates repression of the put operon in Salmonella typhimurium. Gene. 118(1). 13–19. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact